1. P-NGAL Day 1 predicts early but not one year graft function following deceased donor kidney transplantation – The CONTEXT study.
- Author
-
Nielsen, Marie B., Krogstrup, Nicoline V., Nieuwenhuijs-Moeke, Gertrude J., Oltean, Mihai, Dor, Frank J. M. F., Jespersen, Bente, and Birn, Henrik
- Subjects
KIDNEY transplantation ,ORGAN donors ,LIPOCALIN-2 ,ENZYME-linked immunosorbent assay ,GLOMERULAR filtration rate ,CLINICAL trials - Abstract
Background: Early markers to predict delayed kidney graft function (DGF) may support clinical management. We studied the ability of four biomarkers (neutrophil gelatinase associated lipocalin (NGAL), liver-type fatty acid-binding protein (L-FABP), cystatin C, and YKL-40) to predict DGF after deceased donor transplantation, and their association with early graft function and GFR at three and twelve months. Methods: 225 deceased donor kidney transplant recipients were included. Biomarkers were measured using automated assays or ELISA. We calculated their ability to predict the need for dialysis post-transplant and correlated with the estimated time to a 50% reduction in plasma creatinine (tCr50), measured glomerular filtration rate (mGFR) and estimated GFR (eGFR). Results: All biomarkers measured at Day 1, except urinary L-FABP, significantly correlated with tCr50 and mGFR at Day 5. Plasma NGAL at Day 1 and a timed urine output predicted DGF (AUC = 0.91 and AUC 0.98). Nil or only weak correlations were identified between early biomarker levels and mGFR or eGFR at three or twelve months. Conclusion: High plasma NGAL at Day 1 predicts DGF and is associated with initial graft function, but may not prove better than P-creatinine or a timed urine output. Early biomarker levels do not correlate with one-year graft function. Trial registration: ClinicalTrials.gov [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF